Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Thera
(NQ:
VKTX
)
51.71
+0.81 (+1.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,326,339
Open
50.81
Bid (Size)
51.00 (1)
Ask (Size)
51.72 (1)
Prev. Close
50.90
Today's Range
48.78 - 51.96
52wk Range
8.280 - 99.41
Shares Outstanding
99,581,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.
Today 9:20 EDT
Eli Lilly is still a smart pick, but these two stocks could grow more in the near term.
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
They're small now, but these stocks could grow much larger.
Via
The Motley Fool
Performance
YTD
+182.88%
+182.88%
1 Month
-1.95%
-1.95%
3 Month
-19.01%
-19.01%
6 Month
+126.40%
+126.40%
1 Year
+256.37%
+256.37%
More News
Read More
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
Via
Investor's Business Daily
3 Undervalued Biotech Stocks With Breakout Potential
July 19, 2024
Via
InvestorPlace
Smart Money Is Betting Big In VKTX Options
July 18, 2024
Via
Benzinga
Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity
July 05, 2024
Via
Benzinga
Is Viking Therapeutics a Millionaire-Maker?
July 19, 2024
Via
The Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
July 18, 2024
Via
InvestorPlace
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
July 17, 2024
Via
Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Via
Investor's Business Daily
Is Viking Therapeutics the Best Biotech Stock for You?
July 17, 2024
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
July 12, 2024
Via
InvestorPlace
Is Viking Therapeutics Stock Running Out of Steam?
July 11, 2024
Via
The Motley Fool
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
July 10, 2024
Via
The Motley Fool
Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
July 09, 2024
Via
MarketBeat
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
Via
The Motley Fool
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Via
InvestorPlace
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
Via
InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Via
The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
July 03, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Via
InvestorPlace
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Via
MarketBeat
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.